Featured Stories
Canadian Warning Issued for Actos Bladder Cancer Side Effect Risk

Canadian Warning Issued for Actos Bladder Cancer Side Effect Risk

Health Canada has become the most recent national drug regulator to issue a warning about Actos and bladder cancer. Last month, the agency warned that interim results from a 10-year-study indicated that patients taking Actos for more than a year faced an increased risk of bladder cancer. Health Canada also ...

Read More

Pennsylvania Health System Proposes Comprehensive Fracking Study

Pennsylvania Health System Proposes Comprehensive Fracking Study

A proposed study would examine the health effects of hydraulic fracturing (fracking) drilling on the people living closest to active natural gas wells.

Read More

Lawsuits over DePuy ASR Metal-on-Metal Hip Implants Continue to Mount

Lawsuits over DePuy ASR Metal-on-Metal Hip Implants Continue to Mount

DePuy Orthopaedics and its parent, Johnson & Johnson, continue to be hit with lawsuits over recalled metal-on-metal DePuy ASR hip implants. Just yesterday, the national law firm of Parker Waichman LLP announced it had filed yet another DePuy ASR hip implant lawsuit, this time on behalf of a Virginia resident ...

Read More

Another Metal-on-Metal Hip Replacement Lawsuit Filed in DePuy ASR Hip Implant Litigation

Another Metal-on-Metal Hip Replacement Lawsuit Filed in DePuy ASR Hip Implant Litigation

A vital food safety program was saved from budget cuts this week, enabling the country’s largest—although considered by experts to be far too small—produce-safety testing program to continue.

Read More

Another Metal-on-Metal Hip Replacement Lawsuit Filed in DePuy ASR Hip Implant Litigation

Another Metal-on-Metal Hip Replacement Lawsuit Filed in DePuy ASR Hip Implant Litigation

A vital food safety program was saved from budget cuts this week, enabling the country’s largest—although considered by experts to be far too small—produce-safety testing program to continue.

Read More

Indiana Woman Alleges Serious Injuries From Transvaginal Mesh Products

Indiana Woman Alleges Serious Injuries From Transvaginal Mesh Products

Parker Waichman LLP, a national law firm, just filed a lawsuit on behalf of a woman who suffered injuries after receiving transvaginal mesh implants. The lawsuit suit alleges that the transvaginal mesh created an unreasonable risk and directly caused her injuries.

Read More

First DePuy ASR Hip Implant Lawsuits Head to Trial in December, January

First DePuy ASR Hip Implant Lawsuits Head to Trial in December, January

The first trials involving lawsuits filed against DePuy Orthopaedics by recipients of its recalled ASR Hip Implants will begin later this year, and early next year. The first is slated to start on December 3, 2012 in state court in Las Vegas, Nevada. A second DePuy ASR hip implant lawsuit ...

Read More

Oklahoma Woman Latest to Head to Court Over Alleged DePuy ASR Hip Implant Injuries

Oklahoma Woman Latest to Head to Court Over Alleged DePuy ASR Hip Implant Injuries

Lawsuits filed by alleged victims of DePuy Orthopaedics’ recalled ASR hip replacement devices continue to pile up in the multidistrict litigation currently underway in U.S. District Court, Northern District of Ohio. Most recently, a woman from Pryor, Oklahoma, filed suit alleging complications caused by a DePuy ASR hip implant ...

Read More

Actos, Avandia May Up Risk for Diabetic Macular Edema

Actos, Avandia May Up Risk for Diabetic Macular Edema

A West Virginia man fitted with a metal-on-metal version of DePuy Orthopaedics’ Pinnacle Hip Implant System has filed suit against the company and its parent, Johnson & Johnson, alleging the device caused him to suffer pain and elevated cobalt levels. The Plaintiff is being represented by the national law ...

Read More

Canadian Study Finds Actos Raises Bladder Cancer Risk by 22 Percent

Canadian Study Finds Actos Raises Bladder Cancer Risk by 22 Percent

Yet another study is confirming the association between the diabetes drug, Actos, and bladder cancer. This latest research, published today in the Canadian Medical Association Journal, found that taking Actos raised the risk of bladder cancer among diabetics by about one-fifth.

Read More

Alarming Rate of Use of Antipsychotic Drugs in Nursing Homes

A Canadian newspaper’s investigative report reveals an alarming increase in the use of powerful antipsychotic drugs in nursing homes, despite warnings that these medications are dangerous – even lethal – for elderly patients with dementia.

The Toronto Star (thestar.com) found that some long-term care facilities, often short staffed, routinely use these drugs to calm and “restrain” wandering, agitated and sometimes aggressive patients. The Star found that as many as one half of residents at some facilities are on antipsychotics. Continue reading

Posted in Health Concerns, Nursing Home Abuse |

FDA Warns of Cancer Risk with Fibroid Removal Procedure

On Thursday, the U.S. Food and Drug Administration (FDA) cautioned doctors about the use of a procedure in hysterectomy and uterine fibroid tumor removal that could unexpectedly spread cancerous tissue into the patient’s abdomen.

The procedure, power morcellation, involves a device to cut tissue into pieces that can be removed through the tiny incisions made during minimally invasive surgery, The New York Times reports. But, according to FDA data, approximately one in every 350 women with fibroids could have a uterine sarcoma and slicing up the cancerous tissue could allow it to spread in the patient’s abdomen, reducing the patient’s long-term survival rate, according to Law360. Though the FDA stopped short of removing power morcellators from the market, it warned doctors to consider other treatment methods for symptomatic fibroids. Surgeons are taught, the Times explains, that cancers or potentially cancerous tissue should be removed whole and not broken up or cut, to avoid spreading the disease. Continue reading

Posted in Defective Medical Devices, Health Concerns |

Study: Misdiagnosis occurs in 1 out of Every 20 Outpatients

outpatient_misdiagnosis_studyA new study suggests that at least 1 in every 20 outpatients-those who receive care without being admitted to a hospital-experience a misdiagnosis. The study, which was published in the journal BMJ Quality & Safety, found that the rate of misdiagnosis in outpatients was about 5 percent. This translates to 1 in 20 adults, 12 million people when applied to the entire US population. Continue reading

Posted in Legal News |

FDA Send Endo Warning Letter Over Vaginal Mesh Facility

FDA_warns_endo_transvaginal_mesh_facilityFollowing an inspection by federal regulators, pharmaceutical firm, Endo International PLC, was sent a warning letter by the U.S. Food and Drug Administration (FDA) over issues discovered at a vaginal mesh facility.

The inspection was conducted at an Endo subsidiary’s Minnesota facility, Endo wrote this week in a regulatory filing with the U.S. Securities and Exchange Commission (SEC), according to Law360. Endo wrote that the April 10 warning letter came after issues were identified by the FDA following an inspection of a Minnetonka, Minnesota facility operated by its subsidiary, American Medical Systems Inc. (AMS). Continue reading

Posted in Defective Medical Devices, Transvaginal mesh |

SSRI Antidepressant Use in Pregnancy Tied to Autism Risk

pregnant_woman_antidepressants_risk_autismA new study reports that boys with autism were three times more likely to have been exposed to SSRI antidepressants (selective serotonin reuptake inhibitors)  in the womb than typically developing children.

Boys whose mothers took SSRIs – including Celexa (citalopram), Lexapro (escitalopram), Paxil (paroxetine), Prozac (fluoxetine), and Zoloft (certaline) – during pregnancy were also more likely to have developmental delays, HealthDay News reports. The study was published online this week in Pediatrics and will appear in May in the print issue. Continue reading

Posted in Health Concerns, Pharmaceuticals, SSRI Antidepressants |

Harm from E-cigarettes Increase as Their Popularity Rises

Harm_from_E-cigarettes_IncreasesReports of injuries and other harm from e-cigarettes – burns, nicotine toxicity, respiratory and cardiovascular problems – have risen in the past year as the devices become more popular, recent data show.

More than 50 e-cigarette complaints were filed with the U.S. Food and Drug Administration (FDA) between March 2013 and March 2014, Reuters reports. This about equals combined numbers for the previous five years. Continue reading

Posted in Health Concerns, Toxic Substances |

Paralysis a Potential Complication of Spine Stimulators

Paralysis_Potential_in_Spine_StimulatorsSome patients who have been implanted with spinal-cord stimulators have ended up with paralysis, Wall Street Journal reports. These devices are manufactured by a number of companies, the biggest of which include Medtronic, St. Jude Medical and Boston Scientific. The devices use stimulation therapy to help manage chronic pain; a small external remote is used to send low currents of electricity to the implanted generator and the electrical current from the leads creates a tingling sensation that it supposed to mask pain signals being sent to the brain, WSJ says. According to a Wall Street Journal analysis of the U.S. Food and Drug Administration’s (FDA) adverse-event reports and a review of medical malpractice lawsuits, more than 100 patients have experienced partial or permanent paralysis after having a spinal-cord stimulator inserted into their backs. Continue reading

Posted in Legal News |

GM Car Owners File Class Action Over Defective Ignition Switches

GM_Ignition_Switch_RecallA federal class action alleges that General Motors Corp. fraudulently concealed a defect in the ignition switches of 2.6 million Chevrolet, Pontiac and Saturn vehicles, and that the defect is linked to at least 13 deaths.

The complaint, Ruff v. General Motors, was filed Monday in Trenton, New Jersey, and it claims company engineers first learned in 2001 that ignition switches in these vehicles can accidentally move from the “run” to the “accessory” or “off” position, shutting off the engine and disabling such systems as power steering, antilock brakes, and air bags, the New Jersey Law Journal (Law.com) reports. Plaintiffs claim the number of deaths may be far higher than the 13 GM has acknowledged. They cite 303, from a study of airbag deployment failures in crashes of Chevrolet Cobalt and Saturn Ion cars. Continue reading

Posted in Accident, Class Action Lawsuits, Defective Products, Legal News, Motor Vehicles, Product Recalls, Recalled Vehicles |

Sporting Equipment Company STX Recalls Lacrosse Goalie Throat Shield Protector Over Injury Hazard

STX_Recalls_Lacrosse_Goalie_Throat_Shield_ProtectorThe Consumer Product Safety Commission (CPSC) has announced the recall of the STX  Shield Throat Protector because the product can crack or break when struck by a lacrosse ball, posing an injury risk to the user.

The STX Shield throat protector is black and has the letters STX engraved on the outer surface of the protector. The shield attaches to the goalie’s helmet below the chin guard with straps on each side and the bottom. The shield sold for $20 to $25 at specialty sporting goods stores such as Athlete’s Connection, Commonwealth Lacrosse, Lacrosse Unlimited, Play It Again Sports, Sport Stop USA and Universal Lacrosse and online at www.LAX.com from September 2013 through February 2014.

STX has received one report of the throat protector breaking, which reportedly resulted in bruising and lacerations to the user’s neck, according to the CPSC.

The CPSC said consumers should stop using the Shield and return the product to STX for a full refund. Consumers can contact STX toll-free at 888.789.7894, 8:30 a.m. to 5 p.m. ET Monday through Friday or online at www.stx.com.  Click on RECALL–Shield Throat Protector for more information. Continue reading

Posted in Product Recalls |

FDA Warning Letter Issued to Maker of ‘Craze’ Workout Supplement

FDA_warns_makers_of_CRAZE_regarding_ingredientMatt Cahill, who runs Driven Sports, has received a warning letter from the U.S. Food and Drug Administration (FDA) over concerns about the ingredients in Craze, a controversial workout supplement that is reported to have a methamphetamine-like compound. According to the letter, the agency questions whether several ingredients that are claimed to be from dendrobium orchids actually come from the plant. The FDA says that the proprietary blend of ingredients listed as “Dendrobex” made the product adulterated under federal law, since the agency was not aware of evidence that the ingredient was present in food supply. Additionally, the company never submitted any paperwork to have it permitted as a new dietary ingredient. Continue reading

Posted in Legal News |